肺癌篩檢市場規模、佔有率和成長分析（按癌症類型、診斷類型、最終用戶和地區）- 產業預測 2025-2032

2023 年全球肺癌篩檢市場規模價值為 35 億美元，預計將從 2024 年的 38.2 億美元成長到 2032 年的 76.6 億美元，預測期間（2025-2032 年）的複合年成長率為 9.1%。

受篩檢技術進步和菸草使用率上升的推動，全球肺癌篩檢市場預計將經歷顯著成長。據報道，2021 年約有 255 萬名學生消費菸草製品，截至 2020 年，美國約有 13% 的成年人吸煙，肺癌發病率的增加推動了對有效篩檢解決方案的需求。低劑量電腦斷層掃描（CT）在醫療保健專業人士中越來越受歡迎，尤其是在印度和中國等開發中國家，人們對這種創新篩檢技術的認知日益加深。合作努力也正在出現，例如合作宣傳計劃。然而，篩檢的高成本和對輻射暴露的擔憂是顯著的挑戰。透過技術進步和公眾教育解決這些問題對於市場持續成長至關重要。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 技術進步
• 監管格局
• 專利分析

肺癌篩檢市場規模（按癌症類型和複合年成長率） (2025-2032)

• 市場概況
• 非小細胞肺癌（NSCLC）
• 小細胞肺癌

肺癌篩檢市場規模（依診斷類型和複合年成長率）（2025-2032）

• 市場概況
• 低劑量螺旋電腦斷層掃描
• 胸部 X 光檢查

肺癌篩檢市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院和診所
• 診斷中心

肺癌篩檢市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• General Electric Company（USA）
• Koninklijke Philips NV（Netherlands）
• Siemens Healthineers（Germany）
• Canon Medical Systems Corporation（Japan）
• FUJIFILM Holdings Corporation（Japan）
• Medtronic（USA）
• Nuance Communications, Inc.（USA）
• Eon（USA）
• Volpara Health Limited（New Zealand）
• Hitachi, Ltd.（Japan）
• Toshiba Corporation（Japan）
• Hologic, Inc.（USA）
• Agfa-Gevaert Group（Belgium）
• Carestream Health（USA）
• Mindray Medical International Limited（China）
• Esaote SpA（Italy）
• Shimadzu Corporation（Japan）
• ViewRay, Inc.（USA）

結論和建議

Global Lung Cancer Screening Market size was valued at USD 3.5 billion in 2023 and is poised to grow from USD 3.82 billion in 2024 to USD 7.66 billion by 2032, growing at a CAGR of 9.1% during the forecast period (2025-2032).

The global lung cancer screening market is poised for significant growth, fueled by advancements in screening technologies and the rising prevalence of tobacco use. With approximately 2.55 million students reportedly consuming tobacco products in 2021 and nearly 13% of U.S. adults smoking cigarettes as of 2020, the increasing incidence of lung cancer heightens the demand for effective screening solutions. Low-dose computed tomography (CT) is gaining traction among healthcare professionals, particularly in developing countries like India and China, where awareness of innovative screening techniques is on the rise. Collaborative initiatives, such as partnerships for awareness programs, have also emerged. However, high screening costs and concerns about radiation exposure present notable challenges. Addressing these issues through technological advancements and public education will be vital for sustained market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lung Cancer Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Lung Cancer Screening Market Segments Analysis

Global Lung Cancer Screening Market is segmented by Cancer Type, Diagnosis Type, End-user and region. Based on Cancer Type, the market is segmented into Non-small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer. Based on Diagnosis Type, the market is segmented into Low Dose Spiral CT Scan and Chest X-ray. Based on End-user, the market is segmented into Hospitals & Clinics and Diagnostic Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Lung Cancer Screening Market

The Global Lung Cancer Screening market is significantly propelled by the alarming rise in lung cancer cases, which continues to be one of the foremost causes of cancer-related fatalities across the globe. This increasing prevalence, particularly in developing nations, highlights an urgent need for effective early detection methods. Consequently, there is a growing impetus for the implementation of screening programs aimed at identifying lung cancer at its initial stages. As awareness of lung cancer's impact rises, healthcare systems are increasingly prioritizing screening initiatives, thereby fostering the expansion and development of the lung cancer screening market on a global scale.

Restraints in the Global Lung Cancer Screening Market

The Global Lung Cancer Screening market faces several challenges, particularly associated with the use of Low-Dose Computed Tomography (LDCT) screenings. These screenings can sometimes yield false-positive results, necessitating further tests and creating unwarranted anxiety for patients. Additionally, these unnecessary investigations can incur extra costs and may even expose patients to complications arising from unnecessary procedures. Another concern is the issue of overdiagnosis, where patients are identified with lung nodules that are unlikely to cause harm. This situation can result in overtreatment and invasive interventions, complicating the overall management of patients and negatively impacting their quality of life.

Market Trends of the Global Lung Cancer Screening Market

The Global Lung Cancer Screening market is increasingly moving towards personalized screening approaches, reflecting a significant trend characterized by the customization of screening strategies based on individual risk factors such as smoking history, occupational exposures, and genetic predispositions. By implementing risk stratification algorithms, healthcare providers can identify high-risk populations more effectively, thereby optimizing resource allocation and enhancing the overall efficacy of screening interventions. This shift not only improves early detection rates but also aligns with the broader healthcare movement towards precision medicine, ultimately driving market growth as stakeholders invest in technologies and solutions that cater to diverse patient profiles and enhance healthcare outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Patent Analysis

Global Lung Cancer Screening Market Size by Cancer Type & CAGR (2025-2032)

• Market Overview
• Non-small Cell Lung Cancer (NSCLC)
• Small Cell Lung Cancer

Global Lung Cancer Screening Market Size by Diagnosis Type & CAGR (2025-2032)

• Market Overview
• Low Dose Spiral CT Scan
• Chest X-ray

Global Lung Cancer Screening Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Diagnostic Centers

Global Lung Cancer Screening Market Size & CAGR (2025-2032)

• North America (Cancer Type, Diagnosis Type, End-user)
  • US
  • Canada
• Europe (Cancer Type, Diagnosis Type, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Cancer Type, Diagnosis Type, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Cancer Type, Diagnosis Type, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Cancer Type, Diagnosis Type, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• General Electric Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuance Communications, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eon (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Volpara Health Limited (New Zealand)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert Group (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esaote S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ViewRay, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations